Browse site A – Z

Your views

Your Views

Your feedback is vital to us as we continue to increase the quality of our services.

Your views

You are here:

Date: 23 February 2024

Time: 02:47

Image: Institute of Translational Medicine (ITM) logo and front of building

Institute of Translational Medicine (ITM)

The Institute of Translational Medicine (ITM) is a new world class clinical research facility in Birmingham, led by Birmingham Health Partners (BHP).

The ITM will speed up the rate at which research can improve patient treatments and outcomes by using a multi-disciplinary, highly-collaborative approach that will include all components of the bench-to-bedside pathway. It will facilitate the rapid and cost-effective assessment of new drugs, medical devices and diagnostics to quickly bring them to market and front line clinical use.

The centre will also help progress the very latest scientific research findings from the University into enhanced treatments for patients across a range of major health issues including cancer and liver disease.

Internal room bookings

If you are a resident of the ITM and would like to book an internal room on the first, second or fourth floor, please email the ITM booking staff.


Access to the ITM and office accommodation

If you require regular access to the ITM or would like to enquire about becoming a resident, please contact the ITM administration team.

Tel: 0121 371 8001


External websites will open in a new browser window.

University Hospitals Birmingham NHS Foundation Trust is not responsible for the contents or the reliability of external websites and does not necessarily endorse the views expressed within them. Listing should not be taken as endorsement of any kind. We cannot guarantee that links to other websites will work all of the time, and we have no control over the availability of external web pages.

We're improving the accessibility of our websites. If you can't access any content or if you would like to request information in another format, please view our accessibility statement.